azelnidipine has been researched along with natriuretic peptide, brain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enomoto, S; Iwao, H; Izumi, Y; Kusuyama, T; Matsumoto, R; Nishiya, D; Omura, T; Takeuchi, K; Yoshiyama, M | 1 |
| Ito, S; Kawano, T; Koshiba, K; Mikawa, J; Nada, T; Nomura, M | 1 |
| Ishii, K; Ito, H; Iwakura, K; Nagano, T; Nakamura, F; Takiuchi, S | 1 |
| Dobashi, S; Fujii, T; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Oka, T | 1 |
1 trial(s) available for azelnidipine and natriuretic peptide, brain
| Article | Year |
|---|---|
Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: multi-center study with echocardiography.
Topics: Adult; Aged; Aged, 80 and over; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Natriuretic Peptide, Brain; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Young Adult | 2009 |
3 other study(ies) available for azelnidipine and natriuretic peptide, brain
| Article | Year |
|---|---|
The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction.
Topics: Animals; Azetidinecarboxylic Acid; Blotting, Northern; Calcium Channel Blockers; Chemokine CCL2; Collagen Type I; Collagen Type III; Dihydropyridines; Echocardiography; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Organ Size; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity.
Topics: 3-Iodobenzylguanidine; Adipokines; Aged; Antihypertensive Agents; Antioxidants; Arteriosclerosis; Autonomic Nervous System; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cardiomegaly; Carotid Arteries; Catecholamines; Cytokines; Dihydropyridines; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Pulse; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Azelnidipine is a useful medication for the treatment of heart failure preserved ejection fraction.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Echocardiography; Female; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging; Renin-Angiotensin System; Stroke Volume | 2017 |